Patent · US Active

3-phenylpyrazolo[5,1-b]thiazole compounds

US8431603B2 · kind B2 · utility

0Cited by
43References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 9, 2009
Grant dateApr 30, 2013
Priority date—
Expiry dateJul 9, 2029

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P25/32
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A compound represented by the following formula (I), or salt thereof exhibits excellent CRF receptor antagonism, and sufficient pharmacological activity, safety and pharmacokinetic properties as a drug.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.